title: Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase.
abstract: High counts of circulating microparticles, originated from the membrane of abnormal erythrocytes, have been associated with increased thrombotic risk in hemolytic disorders. Our studies indicate that in thalassemia intermedia patients the number of circulating microparticles correlates with the capability of the thalassemic erythrocytes to release microparticles. The microparticles are characteristically loaded with hemichromes formed by denatured α-chains. This finding was substantiated by the positive correlation observed in thalassemia intermedia patients between the amount of hemichromes measured in erythrocytes, their capability to release microparticles and the levels of plasma hemichromes. We observed that hemichromes, following their binding to the cytoplasmic domain of band 3, induce the formation of disulfide band 3 dimers that are subsequently phosphorylated by p72Syk kinase. Phosphorylation of oxidized band 3 appears to be relevant for the formation of large hemichromes/band 3 clusters that, in turn, induce local membrane instability and the release of microparticles. Proteomic analysis of microparticles released from thalassemia intermedia erythrocytes indicated that, besides hemichromes and clustered band 3, the microparticles contain a characteristic set of proteins that includes catalase, heat shock protein 70, peroxiredoxin 2 and carbonic anhydrase. High amounts of immunoglobulins and C3 have also been found to be associated with microparticles, accounting for their intense phagocytosis. The effect of p72Syk kinase inhibitors on the release of microparticles from thalassemia intermedia erythrocytes may indicate new perspectives for controlling the release of circulating microparticles in hemolytic anemias.
authors.affiliation: francesco.turrini@unito.it.
authors.forename: Emanuela
authors.initials: E
authors.lastname: Ferru
authors.forename: Antonella
authors.initials: A
authors.lastname: Pantaleo
authors.forename: Franco
authors.initials: F
authors.lastname: Carta
authors.forename: Franca
authors.initials: F
authors.lastname: Mannu
authors.forename: Amina
authors.initials: A
authors.lastname: Khadjavi
authors.forename: Valentina
authors.initials: V
authors.lastname: Gallo
authors.forename: Luisa
authors.initials: L
authors.lastname: Ronzoni
authors.forename: Giovanna
authors.initials: G
authors.lastname: Graziadei
authors.forename: Maria Domenica
authors.initials: MD
authors.lastname: Cappellini
authors.forename: Francesco
authors.initials: F
authors.lastname: Turrini
mesh_terms: D055252:Cell-Derived Microparticles / Q000378:metabolism*; D004789:Enzyme Activation; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D006420:Hemeproteins / Q000378:metabolism*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D010084:Oxidation-Reduction; D010766:Phosphorylation; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000072377:Syk Kinase; D013789:Thalassemia / Q000097:blood / Q000378:metabolism*
chemical_list: D006420:Hemeproteins; D047908:Intracellular Signaling Peptides and Proteins; D047428:Protein Kinase Inhibitors; C001332:hemichrome; D011505:Protein-Tyrosine Kinases; C000606896:SYK protein, human; D000072377:Syk Kinase
references.citation: Br J Haematol. 2002 Sep;118(3):893-8
references.pmid: 12181063
references.citation: Blood Cells Mol Dis. 2008 May-Jun;40(3):312-6
references.pmid: 18249014
references.citation: Ann N Y Acad Sci. 2005;1054:317-24
references.pmid: 16339680
references.citation: Br J Haematol. 2000 Nov;111(2):467-73
references.pmid: 11122086
references.citation: Haematologica. 2009 Oct;94(10):1445-8
references.pmid: 19794088
references.citation: Environ Health Perspect. 1985 Dec;64:321-30
references.pmid: 3007097
references.citation: Blood. 2004 Nov 15;104(10):3364-71
references.pmid: 15280204
references.citation: Nature. 1969 Apr 19;222(5190):248-50
references.pmid: 4305116
references.citation: Br J Haematol. 1983 Dec;55(4):709-10
references.pmid: 6671089
references.citation: J Thromb Haemost. 2010 Oct;8(10):2152-8
references.pmid: 20546125
references.citation: Am J Physiol Heart Circ Physiol. 2004 May;286(5):H1910-5
references.pmid: 15072974
references.citation: Blood. 1972 Jun;39(6):794-800
references.pmid: 4337623
references.citation: Br J Haematol. 1999 Mar;104(3):504-12
references.pmid: 10086787
references.citation: Nature. 1970 Aug 15;227(5259):680-5
references.pmid: 5432063
references.citation: Blood. 2008 Nov 1;112(9):3900-6
references.pmid: 18698006
references.citation: Br J Haematol. 2011 Mar;152(5):512-23
references.pmid: 21250971
references.citation: J Biol Chem. 1987 Apr 5;262(10):4592-6
references.pmid: 3558357
references.citation: J Biol Chem. 1971 May 25;246(10):3342-55
references.pmid: 4324897
references.citation: Can J Cardiol. 2010 Apr;26(4):140-5
references.pmid: 20386775
references.citation: Br J Haematol. 2008 Jul;142(1):126-35
references.pmid: 18422994
references.citation: Am J Hematol. 2011 Jan;86(1):89-92
references.pmid: 21064134
references.citation: Am J Hematol. 1997 Jun;55(2):83-8
references.pmid: 9209003
references.citation: J Immunol. 2011 Jun 1;186(11):6543-52
references.pmid: 21525379
references.citation: J Biol Chem. 1971 May 25;246(10):3356-66
references.pmid: 4324898
references.citation: Cytometry B Clin Cytom. 2004 Jan;57(1):23-31
references.pmid: 14696060
references.citation: Proc Natl Acad Sci U S A. 1987 Nov;84(21):7368-72
references.pmid: 3313392
references.citation: Blood Cells Mol Dis. 2006 Jul-Aug;37(1):12-20
references.pmid: 16737833
references.citation: Semin Hematol. 1990 Jan;27(1):70-82
references.pmid: 2405497
references.citation: Autoimmun Rev. 2008 Jun;7(6):457-62
references.pmid: 18558362
references.citation: Am J Pediatr Hematol Oncol. 1979 Winter;1(4):311-30
references.pmid: 397778
references.citation: Int J Hematol. 2003 Apr;77(3):299-303
references.pmid: 12731676
references.citation: Blood. 2011 Jun 2;117(22):5998-6006
references.pmid: 21474668
references.citation: J Biol Chem. 1989 Sep 25;264(27):15893-9
references.pmid: 2476434
references.citation: Proteomics. 2010 Oct;10(19):3469-79
references.pmid: 20799346
references.citation: Mol Membr Biol. 1998 Jul-Sep;15(3):153-8
references.pmid: 9859113
references.citation: Basic Res Cardiol. 2011 Nov;106(6):911-23
references.pmid: 21691898
references.citation: Blood. 1993 Nov 15;82(10):3204-10
references.pmid: 8219209
references.citation: PLoS One. 2011 Jan 05;6(1):e15847
references.pmid: 21246053
references.citation: Blood. 1995 Sep 1;86(5):2014-20
references.pmid: 7655029
references.citation: J Proteomics. 2012 Dec 5;76 Spec No.:239-50
references.pmid: 22705320
references.citation: Blood Cells Mol Dis. 2010 Jun 15;45(1):65-6
references.pmid: 20338791
references.citation: Biochem J. 2009 Mar 1;418(2):359-67
references.pmid: 18945214
references.citation: Transfusion. 2008 Mar;48(3):451-62
references.pmid: 18067507
references.citation: Circulation. 2004 Apr 6;109(13):1653-9
references.pmid: 15023873
references.citation: Cardiology. 2011;118(3):159-63
references.pmid: 21646780
references.citation: Transfus Med Rev. 2006 Jan;20(1):1-26
references.pmid: 16373184
references.citation: J Immunol. 2005 Aug 1;175(3):1464-72
references.pmid: 16034083
references.citation: J Clin Invest. 1977 Apr;59(4):633-40
references.pmid: 845254
references.citation: Thromb Haemost. 2006 Oct;96(4):488-91
references.pmid: 17003927